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Problem: Preeclampsia is a major cause of fetal and maternal mortality and morbidity. 
Disturbed fetal-maternal immune tolerance, and therewith memory T cells, might be 
involved in its etiology. This study aims to give insight into memory T-cell populations 
and its associated cytokines in the decidual layers in early-onset preeclampsia (EO-
PE) and late-onset preeclampsia (LO-PE).
Method of Study: Lymphocytes were isolated from the decidua parietalis and ba-
salis	from	EO-PE	(n	=	6),	LO-PE	(n	=	8)	and	healthy	(n	=	15)	pregnancies.	CD4+ and 
CD8+	central-	(CCR7+),	effector-	(CCR7−), tissue resident- (CD103+), and regulatory- 
(Foxp3+)	 memory	 cell	 (CD45RO+)	 populations	 and	 their	 activation	 status	 (CD69+) 
were	analyzed	using	flow	cytometry.	qRT-PCR	analysis	was	performed	on	decidua	
parietalis and basalis biopsies to detect mRNA expression of interferon-gamma, inter-
leukin-1B, IL2, IL6, IL7, IL8, IL10, IL15, and IL23.
Results: CD4+ central-memory (CM) cell proportions were lower in the decidua pa-
rietalis in LO-PE (P < .0001) and EO-PE (P < .01) compared to healthy pregnancies. 
CD8+ memory (P	<	.05)	and	CD8+ CM (P < .01) cell proportions were also lower in the 
decidua parietalis in EO-PE compared to healthy pregnancies. This was accompanied 
by higher IL15 (P	<	.05)	and	IL23 (P	<	.05)	and	lower	IL7 (P	<	.05)	mRNA	expression	in	
decidua	basalis	biopsies	from	EO-PE	compared	to	healthy	pregnancies,	analyzed	by	
qPCR.
Conclusion: In conclusion, decidual memory T-cell proportions, their activation sta-
tus, and associated cytokines are altered in preeclampsia and might therefore be in-
volved in fetal-maternal immune tolerance and the pathophysiology of preeclampsia.
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1  | INTRODUC TION
Preeclampsia	affects	5%-8%	of	pregnancies	and	 is	a	major	cause	
of fetal and maternal mortality and morbidity.1,2 Preeclampsia has 
a	multifactorial	 etiology	 and	 is	 characterized	 by	 a	 poorly	 estab-
lished or poorly perfused placenta, endothelial cell activation and 
a disturbed immune balance leading to hypertension and multi-or-
gan failure.3 Early-onset preeclampsia (EO-PE) and late-onset 
preeclampsia (LO-PE) are distinguished by onset before or after 
34	 weeks	 of	 gestation.4 For research purposes, this distinction 
is often used, since the pathophysiology and immunopathology 
differs.5,6 EO-PE is associated with disturbed trophoblast inva-
sion, modification of the uterine spiral arteries and fetal growth 
restriction, whereas LO-PE seems associated with trophoblast 
overload with aging of the placenta causing reduced intervillous 
perfusion.5-7
During	 pregnancy,	 immune	 tolerance	 is	 required	 toward	 the	
semi-allogeneic fetus.8-10 Insufficient immune tolerance is associ-
ated with pregnancy complications as preeclampsia,8,9,11 skewing 
away from immune tolerance toward more pregnancy threatening 
immunity.12,13 The decidua is the maternal tissue that interacts 
with fetal cells, being the uterine lining in which the fetal tro-
phoblast anchor.14 Two distinct decidua subtypes are identified, 
characterized	by	a	different	 immunologic	response	and	different	
distribution of T-cell populations.15 The decidua parietalis is the 
maternal tissue around the chorionic sac and is in direct contact 
with the non-invading chorionic trophoblast.14 The decidua basalis 
is the maternal side of the placenta and is invaded by the extra-
villous trophoblast.16 Many different maternal immune cells are 
present in the decidua basalis and parietalis, including memory T 
cells.17-22
Multiple studies provide clues for development of immunologic 
memory to generate appropriate fetal-maternal tolerance and pre-
vent immune-associated pregnancy disorders as preeclampsia.22-24 
Memory T cells are a subset of T cells that have developed after 
a previous encounter with an antigen.25 They are long-living and 
provide immediate protection upon re-exposure to the same an-
tigen.26 Memory T-cell differentiation, survival, and cytokine se-
cretion	are	under	the	influence	of	cytokines	such	as	interleukin-7	
(IL7),	IL15,	and	IL23.27-29 Different memory T-cell populations can 
be distinguished based on migration pattern, protein expression 
profile, and cytokine secretion abilities.26,30,31	 In	 both	 the	 CD4+ 
and	CD8+ cell lineages, central-memory (CM) and effector-mem-
ory (EM) cells are identified.25,32-34 CM cells circulate in the blood 
and migrate preferentially to secondary lymphoid organs.34 Upon 
activation, CM cells can proliferate into EM cells, which circulate 
throughout the body and generate an aggressive response upon a 
secondary	encounter	with	the	memorized	antigen.25,32	Within	the	
CD8+ memory T-cell lineage, tissue-resident memory (TRM) cells 
can be distinguished.31,35 TRM cells do not circulate, but reside in 
tissue.31	In	the	CD4+ cell lineage, TRM cells are detectable at very 
low levels.35 Finally, there is a population of Treg memory cells, 
identified by Foxp3 expression and executing immune regulatory 
and immunosuppressive function.30	CD4+ (general) Treg cells are 
considered key players in fetal tolerance.19	 In	 mice,	 CD4+ Treg 
memory cells have been found to be recruited to the reproduc-
tive tract and are important for pregnancy success,36-38 in humans 
their	importance	has	not	been	proven	yet.	CD4+ Treg memory cells 
are found at the fetal-maternal interface and in the decidua.39,40 
Interestingly, in contrast to the lower proportions of (general) 
Tregs found in preeclampsia,9,19 higher proportions of Treg mem-
ory cells are found in the peripheral blood in pregnancy complica-
tions as preeclampsia compared to healthy controls.41,42
In contrast to their normal function, memory cells may have a 
function in fetal tolerance. In murine models, it has been shown 
that fetal antigen-specific memory T cells are generated during 
pregnancy that persist postpartum and decrease fetal resorp-
tion	 rates	 in	 a	 subsequent	 pregnancy.38,43,44 In human decidua, 
memory	 T	 cells,	 mostly	 CD8+ EM cells, were found with a dif-
ferent phenotype and function compared to memory T cells in 
the peripheral blood.45-47	With	 reduced	 granzyme	B	 and	 perfo-
rin expression, and high PD-1 expression, they appear to be si-
lenced, and however, they remain responsive upon stimulation 
and have high IFN-γ expression.45,46	Some	studies	found	that	the	
memory T-cell populations in the peripheral blood are affected in 
preeclamptic pregnancies.39,48,49 Decidual memory T cells in pre-
eclampsia are not well studied and clear insight into memory T 
cells, and the memory T-cell cytokine milieu is lacking. The aim of 
this study is to evaluate differences in memory T-cell populations 
and memory T cell–associated cytokines in decidual tissue be-




To compare immune cells in healthy women and women with preec-
lampsia,	 placentas	 were	 obtained	 from	 15	 healthy	 women,	 eight	
women with LO-PE, and six women with EO-PE (Table 1). To com-
pare immune cells in healthy women with spontaneous labor and 
healthy women with cesarean section, placentas were obtained from 
15	 healthy	 women	 after	 vaginal	 delivery,	 and	 12	 healthy	 women	
after	scheduled	cesarean	section	(Table	S3).	All	women	had	single-
ton	pregnancies,	 a	 body	mass	 index	<35,	 no	diabetes,	 no	 immune	
abnormalities, and no history of smoking, alcohol, or drug use dur-
ing the current pregnancy. Preeclampsia was defined as gestational 
hypertension	(systolic	blood	pressure	≥140	mmHg	and/or	diastolic	
blood	pressure	>90	mmHg	measured	in	two	different	measurements	
after 20 weeks of gestation) accompanied with either proteinuria 
(>300	mg/24	hours),	uteroplacental	dysfunction,	or	other	maternal	
organ	dysfunction	following	the	International	Society	for	the	Study	
of	 Hypertension	 (ISSHP)	 Guideline.50 Diagnosis of preeclampsia 
before	 34	 weeks	 of	 gestation	 was	 considered	 early-onset	 preec-
lampsia,	 and	 diagnosis	 after	 34	 weeks	 was	 considered	 late-onset	
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preeclampsia	 following	 the	 classification	 of	 the	 ISSHP.4 Placental 
tissue was used for this study according to the code of conduct 
for responsible use following the guideline from the Federation of 
Medical	Scientific	Associations.51 This study, including the consent 
procedure, was approved by the Medical Ethics Review Board of 
the University Medical Center Groningen (UMCG; protocol number 
METc2018/516).
2.2 | Lymphocyte isolation
Placentas and membranes were stored in phosphate-buffered sa-
line	(PBS)	at	4°C	directly	after	delivery	until	analysis	for	a	maximum	
of	 24	 hours.52 The amnion was torn off manually after which the 
decidua parietalis was scraped off the chorion using a cell scraper 
(Corning Incorporated). All visible blood vessels were removed. The 
TA B L E  1   Patient characteristics
Healthy (n = 15) Late-onset preeclampsia (n = 8) Early-onset preeclampsia (n = 6)
Maternal age (y) 28	(24-30) 29	(26.25-28.75) 26.0	±	(25.0-2875)
Ethnicity	(%)
White 86.67 75 100
Assyrian 13.33 25 0
Gestational age (wks) 39.29	(39.0-39.86) 38.14	(37.14-38.79)a 	(P	=	.04) 30.65	(29.29-31.32)a 	
(P < .0001)b 	(P < .0001)
Parity 1 (1-2) 1 (1-2) 1 (1-3)
Body mass index (kg/m2) 24.30	(20.35-26.07) 26.25	(21.65-34.96) 23.85	(21.03-26.85)
Gestational age at onset of preeclampsia (wks) 37.21	(35.97-38.21) 30.0	(28.4-30.71)b 	(P < .0001)
Diastolic	blood	pressure	(mmHg) 80.0	(72.0-81.0) 94.0	(86.75-99.63)a 	(P	=	.0038) 98.50	(89.0-102.5)a 	(P = .0009)
Systolic	blood	pressure	(mmHg) 120.0 (110.0-122.1) 138.8	(131.3-155.0)a 	(P	=	.0079) 152.5	(140.0-172.8)a 	(P = .0002)
Duration of hypertension (days) 4.5	(1.0-14.0) 4.5	(3.0-7.5)
Random urine protein:creatinine ratio 0.80	(0.60-0.93) 9.35	(1.84-17.85)b 	(P	=	.007)
Corticosteroid therapy for fetal lung maturation 
(%	of	patients)
0 0 100a 	(P < .0001)b 	(P < .0001)
Number of days between last dose of 
corticosteroids and childbirth (days)
2.5	(2.0-5.25)
Mode	of	delivery	(%)
Vaginal 66.67 75.0 0a 	(P = .011)b 	(P = .021)
Spontaneous 93.33 37.50 0
Induction on maternal indication 0 62.50 0
Induction on fetal indication 6.67 0 0
CS 33.33 25.0 100a 	(P = .011)b 	(P = .021)
Breech presentation 33.33 0 0
Previous	CS 66.67 50.0 0
Fetal indication 0 50.0 16.67
Maternal indication 0 0 83.33
Birth weight (g) 3410	(3080-3680) 3115	(2698-3361) 1235	(990-1459)a 	(P < .0001)b 	
(P < .0001)
%	Below	10th	percentile	birthweight 0 25 66.67a 	(P	=	.0008)
Fetal	sex	(%	female/male) 40/60 12.5/87.5 66.7/33.3
Time between delivery and start of placental 
processing (hours)
6.50	(0-17.50) 10.5	(1.38-17.75) 17.50	(0.38-19.25)
Amount of cells isolated per mL decidual tissue (106)
Decidua parietalis 0.17	(0.063-0.21) 0.62	(0.34-0.90) 0.11	(0.052-0.39)
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villi were cut from the decidua basalis. The entire decidua parieta-
lis	 and	 decidua	 basalis	were	 digested	 in	 a	 1:2	 dilution	 in	 StemPro	
Accutase	 (Lifetechnologies)	 using	 a	 GentleMACS	 Dissociator	
(Miltenyi). Lymphocytes were isolated by centrifugation over a 
Percoll	(Sigma-Aldrich)	gradient	using	three	different	density	layers:	
68%	Percoll	(ρ	=	1.084	g/mL),	45%	Percoll	(ρ	=	1.056	g/mL)	and	40%	
Percoll (ρ	 =	 1.050	g/mL).	After	 centrifugation	 (30	minutes,	 822	 g,	
20°C)	without	deceleration,	the	lymphocyte	enriched	layer	was	iso-
lated	between	 the	68%	and	45%	Percoll	 layer.	 Lymphocytes	were	
washed	in	PBS	and	centrifuged	(5	minutes,	460	g,	20°C).	Cells	were	
counted using a Beckman coulter counter.
2.3 | Flow cytometry
For viability staining, 106	cells	were	incubated	with	0.001%	PercP-Cy5.5	
Fixable	 Viability	 Stain	 620	 (BD	 Biosciences)	 in	 PBS	 for	 15	 minutes	




(SK3;	 BD	 Biosciences),	 PE-Cy7	 anti-CD8	 (RPA-T8,	 BD	 Biosciences),	
BV510	anti-CD45RO	(UCHL-1;	BD	Biosciences),	APC	anti-CD69	(FN50;	
BD	 Biosciences),	 BV421	 anti-CD103	 (BER-ACT8;	 BD	 Biosciences),	
and	PE	anti-CCR7	(150503;	BD	Biosciences)	in	PBS	at	4°C	in	the	dark	
for	30	minutes.	After	 surface	 staining,	 cells	were	washed	with	PBS,	
permeabilized,	 and	 fixed	 using	 Transcription	 Factor	 buffer	 set	 (BD	
Biosciences). Intracellular staining was performed by incubation with 
Alexa	Fluor	488	anti-Foxp3	(236A/E7;	BD	Biosciences)	in	PBS	at	4°C	
in the dark for 30 minutes. Cells were washed with wash buffer (BD 
Biosciences)	and	were	analyzed	with	a	FACSVerse™	flow	cytometer	
(BD	Biosciences)	 using	 BD	 FACS	 Suite™	 software	 (BD	Biosciences).	
FlowJo	V10	software	(LLC)	was	used	to	analyze	flow	cytometry	data.	An	
overview	of	the	gating	strategy	is	displayed	in	Figure	S1.	After	doublet	
exclusion, lymphocytes were gated in a forward sideward scatterplot 
of the single cells (Figure 1A). Lymphocytes that appeared negative for 
F I G U R E  1  CD4+ memory cells in the decidua parietalis and the decidua basalis. Representative dot plots showing flow cytometric 
analysis	of	decidua	parietalis	live	CD4+	lymphocytes	using	forward/sideward	(FSC/SSC)	scatterplots,	viability	stain	and	CD4	and	CD8	
expression	(A).	Within	the	CD4+	cell	population,	CD4+	central-memory	(CM)	cells	(CCR7+CD45RO+CD4+)	(B),	CD4+ effector-memory (EM) 
cells	(CCR7−CD45RO+CD4+)	(B),	general	CD4+	memory	cells	(CM	+	EM;	CD45RO+CD4+)	(B),	and	CD4+ tissue-resident memory (TRM) cells 
(CD103+CD45RO+CD4+)	(C)	were	identified.	Within	the	general	CD4+	memory	cell	population,	T	regulatory	(Treg)	CD4+ memory cells 
(Foxp3+CD45RO+CD4+)	were	identified	(D).	Proportions	of	general	CD4+	memory	cells	(E),	CD4+	CM	cells	(F),	CD4+	EM	cells	(G),	CD4+ TRM 
cells	(H),	Treg	CD4+	memory	cells	(I),	Treg	CD4+ CM (Foxp3+CCR7+CD45RO+CD4+)	cells	(J),	Treg	CD4+ EM (Foxp3+CCR7−CD45RO+CD4+) 
cells	(K),	and	Treg	CD4+ TRM (Foxp3+CD103+CD45RO+CD4+) cells (L), in the decidua parietalis and the decidua basalis from healthy 
pregnancies and pregnancies complicated by late-onset preeclampsia (LO-PE) or early-onset preeclampsia (EO-PE), shown as proportion 
of	the	CD4+	cell	population.	Symbols	represent	individual	values	per	decidua	with	data	as	median	with	interquartile	range.	Analysis	by	
Kolmogorov-Smirnov	test,	one-way	ANOVA	and	Tukey's	post	hoc	test	or	Kruskal-Wallis	and	Dunn's	post	hoc	test	comparing	the	different	
groups within the decidua parietalis or the decidua basalis; *P	<	.05,	**P < .01, ****P < .0001
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Fixable	Viability	Stain	were	gated	as	viable	lymphocytes	(Figure	1A).	
Within	the	viable	lymphocyte	population,	CD4+	and	CD8+ cells were 
distinguished	 (Figure	1A).	Within	the	CD4+ cell population, the total 
proportion	 of	 CD4+	 memory	 cells	 (CD45RO+CD4+),	 CD4+ CM cells 
(CCR7+CD45RO+CD4+),	 and	 CD4+	 EM	 cells	 (CCR7−CD45RO+CD4+) 
were	identified	(Figure	1B).	CD4+ TRM cells (CD103+CD45RO+CD4+) 
were	identified	by	their	expression	of	CD103	(Figure	1C).	Treg	CD4+ 
memory cell proportions were determined by expression of Foxp3 
(Figure	1D,	Figure	S1G-J).	CD69-positive	cells	were	gated	in	all	CD4+ 
memory	 cell	 subsets	 to	 analyze	 activated	 cells	 (Figure	 2A).	 CD8+ 
cells	 were	 gated	 following	 a	 similar	 strategy.	Within	 the	 CD8+ cell 
population,	 the	 total	 proportion	 of	 CD8+ memory cells (CM + EM; 
CD45RO+CD8+),	CD8+	CM	cells	(CCR7+CD45RO+CD8+),	and	CD8+ EM 
cells	 (CCR7−CD45RO+CD8+)	were	 identified	 (Figure	 3A).	Within	 the	
CD8+	cell	population,	CD8+ TRM cells (CD103+CD45RO+CD8+) were 
identified by expression of CD103 (Figure 3B). No Foxp3+CD8+ mem-
ory	cells	were	observed.	CD69-positive	cells	were	gated	in	all	memory	
CD8+	cell	subsets	(Figure	4A).	Table	2	lists	the	markers	used	to	define	
the different memory T-cell subsets.
2.4 | qRT-PCR
After mechanical separation of the decidua basalis and parietalis, 
biopsies of 1 × 1 cm were taken from the central region of both the 




in RLT buffer (Qiagen). RNA was isolated with an Allprep DNA/RNA 
mini	 kit	 (Qiagen).	 Absorbance-based	 quantification	 of	 each	 RNA	
sample	was	performed	using	a	NanoDrop	Spectrophotometer	(ND-
1000; NanoDrop Technologies Inc). Intactness of RNA samples was 
confirmed in random samples from both the decidua basalis and the 
decidua	parietalis	by	electrophoresis	in	2%	agarose	gel	with	ethidium	
bromide	(0.2	µg).	cDNA	was	transcribed	with	Superscript-II	Reverse	
Transcriptase	 kit	 (Invitrogen).	 Housekeeping	 genes	 hypoxanthine-
guanine phosphoribosyltransferase (HPRT;	 Hs02800695_m1)	 and	
β-actin (ACTB;	Hs99999903_m1)	were	analyzed.	mRNA	expression	
of HPRT was normally distributed and had a lower standard deviation 




Proportions	of	activated	cells	of	the	CD4+	memory	cell	population	(B),	the	CD4+	CM	cell	population	(C),	the	CD4+ EM cell population (D), the 
CD4+	TRM	cell	population	(E),	the	Treg	CD4+	memory	cell	population	(F),	the	Treg	CD4+ CM (Foxp3+CCR7+CD45RO+CD4+) cell population 
(G),	the	Treg	CD4+ EM (Foxp3+CCR7−CD45RO+CD4+)	cell	population	(H),	and	the	Treg	CD4+ TRM (Foxp3+CD103+CD45RO+CD4+) cell 
population (I), in the decidua parietalis and the decidua basalis from healthy pregnancies and pregnancies complicated by late-onset 
preeclampsia	(LO-PE)	or	early-onset	preeclampsia	(EO-PE).	Symbols	represent	individual	values	per	decidua	with	data	as	median	with	
interquartile	range.	Analysis	by	Kolmogorov-Smirnov	test,	one-way	ANOVA	and	Tukey's	post	hoc	test	or	Kruskal-Wallis	and	Dunn's	post	hoc	
test comparing the different groups within the decidua parietalis or the decidua basalis; *P	<	.05,	**P < .01
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compared to mRNA expression of ACTB. Therefore, HPRT was used 
as reference housekeeping gene.53 mRNA expression of memory T 
cell–associated cytokines IL7	(Hs00174202_m1),	IL15	(Hs01003716_
m1), and IL23	 (Hs00372324_m1),	 and	 preeclampsia-associated	 cy-
tokines interferon-γ (IFN-γ;	 Hs00989291_m1),	 interleukin-1β (IL1β; 
Hs00174097_m1),	 IL2	 (Hs00174114_m1),	 IL6	 (Hs00985639_m1),	






Data	 were	 tested	 for	 normality	 using	 Kolmogorov-Smirnov	 test	
(P	 <	 .05).	When	data	were	 normally	 distributed,	 all	 groups	were	
compared	 using	 one-way	 ANOVA	 followed	 by	 Tukey's	 post	 hoc	
test.	When	data	were	distributed	non-normally,	the	Kruskal-Wallis	
test	followed	by	Dunn's	post	hoc	test	was	used.	Fisher's	exact	test	
was used for categorical variables. Depending on parametric or 
nonparametric	distribution,	Pearson	or	Spearman	correlation	co-
efficient tests were used for correlation of mRNA expression with 
memory T-cell proportions and for post hoc analyses to identify 
possible confounders. Correlation coefficients of r	 ≥	 .5	or	 r	 ≤	 .5	
were considered relevant. Linear regression analyses were per-
formed to assess the possible correlation between gestational age 
and memory T-cell proportions. Outliers were excluded follow-
ing the ROUT method.54	Prism	7	software	for	Mac	and	Windows	
(GraphPad	software	 Inc;	Microsoft)	 and	SPSS	 for	Windows,	ver-
sion	 23.0	 software	 (SPSS	 Inc)	 was	 used.	 Differences	 were	 con-
sidered statistically significant if P	 <	 .05.	 A	 P-value < .10 was 
considered a statistical trend.
3  | RESULTS
3.1 | Patient characteristics
An overview of the patient characteristics is provided in Table 1. 
Pregnancies complicated with LO-PE (P	=	.04)	or	EO-PE	(P < .0001) 
had a lower gestational age compared to healthy pregnancies. The 
F I G U R E  3  CD8+ memory cells in 
the decidua parietalis and the decidua 
basalis. Representative dot plots 
showing flow cytometric analysis of 
decidua	parietalis	CD8+ central-memory 
(CM)	cells	(CCR7+CD45RO+CD8+) 
(A),	CD8+ effector-memory (EM) cells 
(CCR7−CD45RO+CD8+)	(A),	general	CD8+ 
memory	cells	(CM	+	EM;	CD45RO+CD8+) 
(A),	and	CD8+ tissue-resident memory 
(TRM) cells (CD103+CD45RO+CD8+) (B), 
identified	in	the	CD8+ cell population. 
Proportions	of	general	CD8+ memory cells 
(C),	CD8+	CM	cells	(D),	CD8+ EM cells (E), 
and	CD8+ TRM cells (F), in the decidua 
parietalis and the decidua basalis from 
healthy pregnancies and pregnancies 
complicated by late-onset preeclampsia 
(LO-PE) or early-onset preeclampsia 
(EO-PE), shown as proportion of the 
CD8+	cell	population.	Symbols	represent	





comparing the different groups within the 
decidua parietalis or the decidua basalis; 
*P	<	.05,	**P < .01
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F I G U R E  4  Activated	CD8+ memory 
cells in the decidua parietalis and 
the decidua basalis. Representative 
dot plots showing flow cytometric 
analysis of decidua parietalis activated 
(CD69+)	general	CD8+ memory cells 
(CM	+	EM;	CD69+CD45RO+CD8+), 
CD8+ central-memory (CM) cells 
(CD69+CCR7+CD45RO+CD8+), 
CD8+ effector-memory (EM) cells 
(CD69+CCR7−CD45RO+CD8+), and 
CD8+ tissue-resident memory (TRM) 
cells	(CD69+CD103+CD45RO+CD8+) 
(A). Proportions of activated cells of 
the	CD8+ memory cell population (B), 
the	CD8+ CM cell population (C), the 
CD8+	EM	cell	population	(D),	the	CD8+ 
TRM cell population (E), in the decidua 
parietalis and the decidua basalis from 
healthy pregnancies and pregnancies 
complicated by late-onset preeclampsia 
(LO-PE) or early-onset preeclampsia 
(EO-PE).	Symbols	represent	individual	





comparing the different groups within the 
decidua parietalis or the decidua basalis; 
*P	<	.05,	**P < .01
TA B L E  2   Memory T-cell subsets and identification markers
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birthweight of babies after pregnancies complicated with EO-PE 
was lower compared to LO-PE (P < .0001) and healthy pregnan-
cies (P	 <	 .0001).	 Systolic	 and	 diastolic	 blood	 pressure	were	 sig-
nificantly higher in EO-PE (P = .0002 and P = .0009) and LO-PE 
(P	=	.0079	and	P	=	.0038)	pregnancies	compared	to	healthy	preg-
nancies. In addition, more babies from EO-PE pregnancies were 
delivered through cesarean section compared to LO-PE pregnan-
cies (P = .021).
3.2 | Decidual CD4+ memory cell subsets in LO-PE, 
EO-PE, and healthy pregnancies
To	investigate	CD4+ memory T-cell proportions at the fetal-maternal 
interface in preeclampsia, flow cytometric analyses were performed 
on lymphocytes isolated from the decidua parietalis and decidua ba-
salis from pregnancies with LO-PE, EO-PE, and healthy pregnancies 
(Figure	1A-D;	Figure	S2).
In	the	decidua	parietalis,	the	total	CD4+ cell proportion of live lym-
phocytes	did	not	significantly	differ	between	the	groups	(Figure	S3).	
Lower	proportions	of	the	general	CD4+ memory cell (P	=	.0096)	pop-
ulation were found in LO-PE compared to healthy pregnancies in the 
decidua	parietalis	(Figure	1E).	Lower	CD4+ CM cell proportions were 
found in the decidua parietalis in EO-PE (P	=	.0073)	and	even	more	in	
LO-PE (P < .0001) compared to healthy pregnancies (Figure 1F). A trend 
toward lower (P	=	.059)	CD4+ TRM cells was found in EO-PE compared 
to	healthy	pregnancies	in	the	decidua	parietalis	(Figure	1H).	Lower	Treg	
CD4+ CM cell proportions were found in the decidua parietalis from 
LO-PE compared to healthy pregnancies (P	=	 .035;	Figure	1J).	There	
were	no	significant	differences	in	any	of	the	CD4+ memory cell subsets 
between EO-PE and LO-PE.
Similar	to	the	decidua	parietalis,	in	the	decidua	basalis,	the	total	
CD4+ cell proportion did not differ between the groups (not shown) 
and	lower	CD4+ CM cells were observed in LO-PE pregnancies com-
pared to healthy pregnancies (P	=	.0407;	Figure	1F).	Apart	from	this	
CD4+ CM cell difference, in the decidua basalis no differences be-
tween	the	groups	were	found	in	any	of	the	other	CD4+ memory cell 
subsets (Figure 1). There were no significant differences in any of the 
CD4+ memory cell subsets between EO-PE and LO-PE.
3.3 | Activated decidual CD4+ memory cell subsets 
in LO-PE, EO-PE, and healthy pregnancies
In the decidua parietalis, a trend toward higher activated propor-
tions	 of	 the	 general	 CD4+ memory cell population was found in 
EO-PE compared to healthy pregnancies (P	 =	 .083;	 Figure	 2B).	
Higher	activated	proportions	of	the	Treg	CD4+ CM (P = .0091), and 
the	Treg	CD4+ TRM (P	=	.047)	cell	populations	were	found	in	EO-PE	
pregnancies compared to healthy pregnancies (Figure 2G,I). The 
total	CD4+ cell (P	=	.017;	not	shown),	the	general	CD4+ memory cell 
(P	=	.019),	CD4+ CM cell (P	=	.0045),	CD4+ EM cell (P = .039), Treg 
CD4+ memory cell (P	=	.047),	Treg	CD4+ CM cell (P = .021), and Treg 
CD4+ TRM cell (P	=	 .041)	populations,	showed	a	higher	activated	
proportion in EO-PE pregnancies compared to LO-PE pregnancies 
(Figure 2B-G,I).
In the decidua basalis, lower activated proportions of the 
CD4+CD45RO+ memory cell population (P	=	.030)	and	the	CD4+ 
EM cell population (P	=	 .0014)	were	found	 in	LO-PE	compared	
to	healthy	pregnancies	(Figure	2B,D).	In	the	CD4+ CM cell pop-
ulation (P	 =	 .0018	and	P	 =	 .0078)	 and	 the	TRM	CD4+ memory 
cell population (P	=	.048	and	P	=	.028),	lower	activated	propor-
tions were found in the decidua basalis from both preeclamptic 
groups (LO-PE and EO-PE, respectively) compared to the con-
trol group (Figure 2C,E). No differences in activation in the total 
CD4+ cell population and in any of the memory T-cell subsets 
were found between the preeclampsia subtypes in the decidua 
basalis.
Comparing the decidua parietalis and basalis, lower activated pro-
portions	of	all	CD4+ memory cell subsets were found in EO-PE in the 
decidua basalis compared to the decidua parietalis (P	<	.05;	Figure	2).
3.4 | Decidual CD8+ memory cell subsets in LO-PE, 
EO-PE, and healthy pregnancies
The	general	CD8+	memory	cell	population,	the	CD8+ CM cell popula-
tion,	the	CD8+	EM	cell	population,	and	the	CD8+ TRM cell population 
were	analyzed	by	flow	cytometry	in	the	decidua	basalis	and	decidua	
parietalis from LO-PE, EO-PE, and healthy pregnancies (Figure 3A,B, 
Figure	S4).
In	 the	decidua	parietalis,	 the	 total	CD8+ cell proportion of live 
lymphocytes did not significantly differ between the groups (Figure 
S3).	 The	 general	CD8+ memory cell population (P = .013) and the 
CD8+ CM cell population (P	 =	 .0064)	 were	 lower	 in	 EO-PE	 com-
pared to healthy pregnancies in the decidua parietalis (Figure 3C,D). 
The	general	CD8+ memory cell population was also lower in LO-PE 
compared to healthy pregnancies in the decidua parietalis (P	=	.034;	
Figure	3C).	CD8+ EM cells showed a trend toward lower proportions 
in EO-PE compared to healthy pregnancies in the decidua parieta-
lis (P	 =	 .063;	 Figure	 3E).	 No	 differences	 were	 observed	 between	
the	groups	 in	CD8+ TRM cell proportions in the decidua parietalis 
(Figure	3F).	The	preeclampsia	subtypes	had	no	effect	on	CD8+ mem-
ory cell proportions in the decidua parietalis.
In	 the	 decidua	 basalis,	 the	 general	 CD8+ memory cell propor-
tion was lower in EO-PE compared to healthy pregnancies (P	=	.042;	
Figure	3C).	No	differences	in	the	total	CD8+ cell population and in 
any	of	the	other	CD8+ memory cell subsets were found between the 
groups in the decidua basalis.
3.5 | Activated decidual CD8+ memory cell subsets 
in LO-PE, EO-PE, and healthy pregnancies
In	 the	 decidua	 parietalis,	 a	 trend	 toward	 higher	 activated	 (CD69+) 
proportions	 of	 the	 general	CD8+ memory cell population (P	 =	 .076),	
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the	CD8+ CM cell population (P	=	.062),	the	CD8+ EM cell population 
(P	=	.095),	and	a	significantly	higher	proportion	of	the	CD8+ TRM cell 
population (P	 =	 .036)	 was	 observed	 in	 EO-PE	 compared	 to	 healthy	
pregnancies	 (Figure	 4B-E).	 When	 comparing	 the	 preeclampsia	 sub-
types,	higher	activated	proportions	of	the	total	CD8+ cell population 
(not	shown),	and	all	CD8+ memory cell subsets were found in EO-PE 
compared to LO-PE in the decidua parietalis (P	<	.05;	Figure	4B-E).	In	
the	decidua	basalis,	 lower	activated	proportions	of	the	general	CD8+ 
memory cell population (P	=	.015),	and	a	trend	toward	lower	activated	
proportions	of	the	CD8+ EM cell population (P	=	.073)	and	CD8+ TRM 
cell population (P	=	 .066)	were	found	 in	LO-PE	compared	to	healthy	
pregnancies	 (Figure	4B,D,E).	Activated	proportions	of	 the	CD8+ CM 
cell population did not differ between the groups in the decidua basalis 
(Figure	4C).	Comparison	of	the	preeclampsia	subtypes	showed	higher	
activated	proportions	of	general	CD8+ memory cells (P	=	.0018),	CD8+ 
EM cells (P	=	.0018)	and	CD8+ TRM cells (P = .011) in EO-PE pregnancies 
compared	to	LO-PE	pregnancies	(Figure	4B,D,E).	Lower	activated	pro-
portions	of	all	CD8+ memory cell subsets were found in EO-PE in the 
decidua basalis compared to the decidua parietalis (P	<	.05;	Figure	4).
3.6 | mRNA expression of memory T cell-associated 
cytokines in biopsies from the decidua parietalis and 
basalis in LO-PE, EO-PE, and healthy pregnancies
In the decidua parietalis, a trend toward higher IL15 mRNA expres-
sion was found in EO-PE pregnancies compared to healthy pregnan-
cies (P	=	 .072;	Figure	5B).	 In	 the	decidua	parietalis,	no	differences	
were found between the groups for IL7 and IL23 mRNA expression 
(Figure	5A,C
).
In the decidua basalis, IL7 mRNA expression was lower in 
EO-PE pregnancies as compared to healthy pregnancies (P	=	 .044;	
Figure	5A).	mRNA	expression	of	IL15 (P = .013) and IL23 (P = .030) 
was higher in the decidua basalis from EO-PE pregnancies compared 
to	 healthy	 pregnancies	 (Figure	 5B,C).	 Also	 in	 the	 decidua	 basa-
lis, a trend toward higher mRNA expression of IL15 (P = .091) and 
significantly higher mRNA expression of IL23 (P = .011) was found in 
LO-PE	compared	to	healthy	pregnancies	 (Figure	5B,C).	Correlation	
analyses in the decidua parietalis showed that mRNA expression of 
IL15	 was	 associated	 with	 activated	 proportions	 of	 CD8+ memory 
cells (P	=	.014,	r	=	.50)	and	CD8+ CM cells (P	=	.0062,	r	=	.54;	Tables	
S1	and	S2).	mRNA	expression	of	 IL7 and IL23 were not associated 
with any of the memory T-cell proportions in either the decidua pa-
rietalis or basalis.
3.7 | mRNA expression of preeclampsia-associated 
cytokines in biopsies from the decidua parietalis and 
basalis in LO-PE, EO-PE, and healthy pregnancies
In the decidua parietalis, IFN-γ showed a trend toward higher mRNA 
expression in EO-PE compared to healthy pregnancies (P	 =	 .065;	
Figure	6A).	Higher	mRNA	expression	of	 IL2 (P	=	 .0064)	was	found	
in the decidua parietalis from EO-PE compared to healthy pregnan-
cies	 (Figure	6C).	No	differences	 in	mRNA	expression	of	 IL1β were 
found	 between	 the	 groups	 in	 the	 decidua	 parietalis	 (Figure	 6B).	
Comparison of the preeclampsia subtypes showed a trend toward 
higher IFN-γ (P = .090) and IL2 (P	=	 .070)	mRNA	expression	and	a	
trend toward lower IL6 (P = .10) and IL8 (P = .10) mRNA expression in 
EO-PE	compared	to	LO-PE	in	the	decidua	parietalis	(Figure	6A,C-E).
In the decidua basalis, higher mRNA expression of IL1β in LO-PE 
(P = .011) and a trend toward higher expression in EO-PE (P	=	.078)	
was	found	compared	to	healthy	pregnancies	(Figure	6B).	Analysis	of	
IL2, IL6, IL8, and IL10 mRNA expression did not show any significant 
differences	between	the	groups	in	the	decidua	basalis	(Figure	6C-F).	
When	comparing	the	effect	of	the	preeclampsia	subtypes	on	mRNA	
expression of preeclampsia-associated cytokines in the decidua 
basalis, a trend toward lower IFN-γ was observed in EO-PE compared 
to LO-PE (P	=	.091;	Figure	6A).
Correlation analyses in the decidua parietalis showed that 
mRNA expression of IFN-γ was associated with activated propor-
tions	 of	 CD8+ memory cells (P	 =	 .0018,	 r	 =	 .62),	 CD8+ CM cells 
(P	=	 .0054,	r	=	 .59),	and	CD8+ TRM cells (P	=	 .0004,	r	=	 .67),	and	
F I G U R E  5   mRNA expression of memory T cell–associated cytokines in the decidua. mRNA expression of IL7 (A), IL15 (B), and IL23 
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that mRNA expression of IL1β	was	associated	with	CD4+ CM cells 
(P = .020, r	=	−.51).	mRNA	expression	of	 IL2 was associated with 
activated	proportions	of	all	CD8+ memory cell subsets (P	<	.01-.05,	
r	=	.51-.58),	and	IL8 was associated with activated proportions of 
CD4+ memory cells (P = .011, r	=	−.52),	CD4+ EM cells (P	=	.0005,	
r	=	−.67),	CD8+ memory cells (P	=	.0084,	r	=	−.54),	and	CD8+ TRM 
cells (P	=	 .0080,	 r	=	−.54;	Table	S1).	 In	 the	decidua	basalis,	 IFN-γ 
mRNA	expression	was	associated	with	CD4+ EM cells (P = .0090, 
r	 =	 .51),	 CD4+ TRM cells (P	 =	 .0036,	 r	 =	 .56),	 CD8+ TRM cells 
(P	=	 .0068,	 r	=	 .53),	and	activated	proportions	of	CD8+ CM cells 
(P = .011, r	=	.50;	Table	S2).
4  | DISCUSSION
In	 this	study,	we	showed	fewer	CD4+	CM	cells	and	CD8+ memory 
cells in the decidua parietalis from EO-PE and LO-PE compared to 
healthy	pregnancies.	All	CD4+	and	CD8+ memory cell subsets ana-
lyzed	in	this	study	had	higher	activated	proportions	in	the	decidua	
parietalis from EO-PE compared to LO-PE. These findings were ac-
companied by lower IL7 mRNA expression and higher mRNA expres-
sion of IL15 and IL23 in the decidua basalis of EO-PE compared to 
healthy pregnancies.
In accordance with previous studies, our study showed that var-
ious memory T-cell subpopulations are present at the fetal-maternal 
interface.15,20	Since	our	methods	were	designed	to	minimize	contam-
ination of decidual T cells with fetal T cells and T cells from mater-
nal	blood	(Figure	S5	and	Supplementary	Methods),	we	consider	the	
memory	T	cells	analyzed	in	this	study,	a	good	representation	of	the	
decidual memory T-cell populations. Previously, Tilburgs et al showed 
that	 CD8+ memory cells at the fetal-maternal interface have de-
creased cytotoxic activity, as they showed reduced levels of perfo-
rin	and	granzyme	B,	but	increased	levels	of	programmed	cell	death-1	
(PD-1).17 Mice studies suggest that the function of memory T cells 
during pregnancy has changed.38,43,44 It may be suggested that mem-
ory T cells are differently regulated at the fetal-maternal interface, 
which	 affects	 their	 function	 and	 keeps	 them	quiescent	 throughout	
pregnancy to generate tolerance to fetal antigens, however, remain 
capable of eliciting an immune response toward pathogens.
Our findings suggest that CM and EM cells are differently main-
tained in decidua tissue. CM and EM cells have different homing ca-
pacities and homing receptors.25,33,34 Contrary to EM cells, CM cells 
express	homing	receptors	CCR7	and	CD62L	which	enables	central	
immune surveillance by patrolling the lymph nodes draining periph-
eral tissues.22,33	However,	our	study	and	various	other	studies	have	
shown that the distinction between CM and EM cells may not be so 
clear, since CM cells are also found in non-lymphoid tissue and in 
these tissues may have effector functions similar to EM cells.17,46,55 
CD4+ CM cells are long-living cells and are able to persist in the cir-
culation for a long time.56 They can also transform into different 
CD4+ cell subsets, including EM cells.56,57	It	may	be	that	CD4+ CM 
cells persist in the circulation after pregnancy. This suggestion is in 
line with our previous study in parous women after uncomplicated 
pregnancies,	which	showed	persisting	higher	levels	of	CD4+ CM cells 
in women postpartum compared to nulligravid women.58 Recently, 
we	found	lower	activated	proportions	of	CD4+ CM cells in women 
after a preeclamptic pregnancy compared to women after a healthy 
pregnancy.59
F I G U R E  6   mRNA expression of preeclampsia-associated cytokines in the decidua. mRNA expression of interferon-γ (IFN-γ) (A), IL1β (B), 
IL2 (C) IL6 (D), IL8 (E), and IL10 (F), in biopsies from the decidua parietalis and the decidua basalis from healthy pregnancies and pregnancies 
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In the present study, we did find Foxp3+	CD4+ memory cells in 
the decidua parietalis and the decidua basalis in both healthy and 
preeclamptic	pregnancies.	 It	 is	 suggested	 that	Treg	CD8+ memory 
cells are distinguished by other markers.60,61	Within	 the	CD4+ cell 
population, we were able to identify Treg CM, Treg EM, and Treg 
TRM	 cells.	 Studies	 using	 transgenic	 mouse	 models	 have	 shown	 a	
Treg	 CD4+ memory cell population with fetal antigen specificity 
which is generated during gestation, remains postpartum and con-
tributes	to	lower	resorption	rates	in	subsequent	pregnancies.38	We	
observed	 lower	Treg	CD4+ CM cells in the decidua parietalis from 
LO-PE	compared	to	healthy	pregnancies.	Other	Treg	CD4+ memory 
cell populations did not differ between healthy and preeclamptic 
pregnancies.	Our	study	may	thus	 indicate	that	Treg	CD4+ memory 
cells in the decidua are not so much affected in preeclampsia. As it 
is known that Treg cells are increased at mid-gestation and decrease 
toward the end of pregnancy,62,63 the lack of a decrease of Treg 
CD4+ memory cells in preeclampsia may also be due to differences 
in gestational age between the groups. The difference in gestational 
age between our groups is a limitation of our study, however, the 
optimal “healthy” preterm cohort which matches the median gesta-
tional	age	of	30.65	weeks	of	gestation	similar	to	that	of	the	patients	
in the EO-PE group is most likely also pathologic, which could there-
fore	 result	 in	 false-negative	 or	 false-positive	 results.	 To	 analyze	 a	
possible effect of gestational age on our results, we performed linear 
regression analyses in the healthy pregnancy group separately and 
in all groups together. These analyses did not show any significant 
effect of gestational age on memory T-cell proportions and also no 
effect on mRNA expression of preeclampsia-associated cytokines 
was observed. It was shown in previous studies that IL15 mRNA ex-
pression in decidual and placental tissues increases with gestational 
age.64,65	We	found	a	trend	toward	higher	IL15 mRNA expression in 
the decidua parietalis and significantly higher IL15 mRNA expression 
in the decidua basalis of the EO-PE group compared to the healthy 
group. This is the opposite of what was expected when looking at 
the gestational age of these groups since the EO-PE group has a 
significantly lower gestational age compared to the healthy group. 
Therefore, the changes found in IL15 mRNA expression are most 
likely due to preeclampsia and not gestational age.
Although	 the	 sample	 size	 of	 our	 study	 is	 limited,	 the	 very	 ho-
mogenous patient groups are a strength. To exclude an effect of 
possible	confounders,	we	performed	several	post	hoc	analyses.	We	
performed correlation analyses to detect possible effects of sample 
processing time on memory cell subsets. As R2 was <.3 for all anal-
yses, we consider the processing time not as a relevant confounder. 
To detect whether mode of delivery might interfere with our results, 
we	analyzed	an	additional	cohort	of	patients	and	found	no	signifi-
cant	differences	in	CD4+	and	CD8+ memory T-cell populations and 
their activated proportions in the decidua basalis and parietalis be-
tween healthy women who delivered through cesarean section and 
healthy	women	who	delivered	vaginally	(Figure	S5).	A	trend	toward	
lower	CD4+	 and	CD8+ memory cells was observed in the decidua 
basalis of women who delivered through cesarean section, and a 
trend	 toward	 lower	 activated	 proportions	 of	 CD8+ memory cells 
was also observed in the decidua basalis of these women. These 
differences were not seen in the cell populations when comparing 
the	preeclamptic	groups	to	the	healthy	group	except	for	the	CD8+ 
memory cell population. Therefore, we conclude that the difference 
in mode of delivery between our preeclamptic and control groups 
does not affect our main findings. Only women in the EO-PE group 
received corticosteroid therapy for fetal lung maturation. Using 
correlation analysis, we found a relevant correlation regarding time 
since	steroid	use	and	levels	of	activated	CD4+ CM cells (R2	=	.70)	in	
the decidua parietalis in the EO-PE group. This indicates that the 
higher	 activated	 CD4+ CM cell proportions that we found in the 
EO-PE compared to the LO-PE group might be due to steroid use. 
Interestingly,	the	activated	CD4+ CM cell population did not differ 
between the EO-PE and the healthy control group, who also did not 
receive steroids. In addition, all other memory T-cell subsets did not 
show any correlation with time since steroid use which suggests only 
very minimal effects on the results. Effects of steroids on memory T 
cells in pregnancy are a relevant subject for future studies, especially 
since the interference of steroids in human immunological studies of 
preeclampsia is unavoidable since it is standard clinical care.
To explore potential mechanisms related to decreased memory 
T-cell populations in the preeclamptic decidua, we measured mRNA 
expression of memory T-cell associated cytokines in decidua pari-
etalis	and	basalis	biopsies.	We	showed	slightly	lower	IL7 mRNA ex-
pression in the decidua basalis in LO-PE and significantly lower IL7 
mRNA	expression	 in	EO-PE	compared	 to	healthy	pregnancies.	 IL7	
promotes	survival	and	self-renewal	of	both	CD4+	and	CD8+ memory 
cell lineages,66,67 which could indicate that the decreased propor-
tions	of	CD8+ memory T-cell populations in the preeclamptic decidua 
basalis	are	due	to	decreased	levels	of	IL7,	and	however,	correlation	
analyses	 did	 not	 show	 a	 relevant	 association.	 IL15	 and	 IL23	 are	
pro-inflammatory	cytokines	that	have	stimulatory	effects	on	CD4+ 
and	CD8+ memory cells, promote long term survival, and induce IFN-
γ,	tumour	necrosis	factor	B,	and	IL17	secretion.27,68-70 Therefore, the 
higher levels of IL15 and IL23 mRNA expression in the decidua basa-
lis from preeclamptic pregnancies and their known stimulatory ef-
fects on memory T cells27,68-70 indicate that these cytokines may not 
be involved in the decreased proportions of memory T cells in the 
decidua. The levels of IL15 in the decidua parietalis might be involved 
in	 the	higher	 activated	proportions	of	CD8+ memory cell subsets, 
since the IL15 mRNA expression was associated with the higher ac-
tivated	proportions	of	CD8+	memory	cells,	CD8+	CM	cells,	and	CD8+ 
TRM cells. Various papers have shown that the decidua parietalis 
and basalis have different functional characteristics and consist of 
a different immune cell repertoire which might be due to differ-
ent	 blood	 supply,	 cell	 recruitment,	 differential	HLA	expression	 on	
trophoblasts and prostaglandin secretion in the different anatomic 
locations.14-16,18,71 These earlier studies showed differences in acti-
vation and proportions of macrophage subsets and T cells.14-16,18,71 
The most prominent difference we found between the two decidual 
compartments in this study are the lower activated proportions of all 
CD4+	and	CD8+ memory cell subsets in EO-PE in the decidua basalis 
compared to the decidua parietalis. An explanation for this might be 
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the cytokines present in the decidua parietalis since correlation anal-
yses showed that activated proportions of the memory T cells were 
associated with IL8, IL15, and IFN-γ mRNA expression in the decidua 
parietalis	and	not	in	the	decidua	basalis.	When	we	compared	EO-PE	
and LO-PE, we found higher activated proportions in almost every 
memory	T-cell	subset	analyzed	in	the	decidua	parietalis	from	EO-PE	
compared	to	LO-PE.	Since	EO-PE	is	associated	with	higher	oxidative	
stress compared to LO-PE,5,6,72 and oxidative stress is associated 
with	higher	CD69	expression,73 the higher activated proportions of 
memory T cells in EO-PE compared to LO-PE in this study may be 
due to higher oxidative stress. Also, excess syncytiotrophoblast mi-
croparticle shedding into the maternal circulation in EO-PE and not 
LO-PE could cause increased activated proportions and higher IFN-γ 
and IL2 mRNA expression in EO-PE compared to LO-PE.74
In conclusion, this study showed that memory T-cell subsets in 
the decidua basalis and parietalis are altered in EO-PE and LO-PE 
compared to healthy pregnancies. In addition, higher activated pro-
portions of memory T cells were found in EO-PE compared to LO-PE 
in the decidua parietalis. These findings were accompanied by lower 
mRNA expression of the memory T cell–stimulating cytokine IL7 
and higher IL15 and IL23 mRNA expression in EO-PE compared to 
healthy	 pregnancies.	We	 hypothesize	 that	memory	 T	 cells	 are	 in-
volved in fetal-maternal tolerance and that the decreased presence 
of specific memory T-cell subsets at the fetal-maternal interface in 
preeclampsia may play a role in the pathophysiology of preeclamp-
sia, that is, decreased fetal tolerance.
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